Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
Background This cost analysis uses data from a randomized trial comparing a no prophylaxis versus prophylactic platelet (PLT) transfusion policy (counts <10 × 109/L) in adult patients with hematologic malignancies.
Egile Nagusiak: | Campbell, H, Estcourt, L, Stokes, E, Llewelyn, C, Murphy, M, Wood, E, Stanworth, S |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Blackwell Publishing Inc.
2014
|
Antzeko izenburuak
-
Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
nork: Campbell, H, et al.
Argitaratua: (2014) -
Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
nork: Stanworth, S, et al.
Argitaratua: (2014) -
Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
nork: Stanworth, S, et al.
Argitaratua: (2014) -
Prophylactic platelet transfusions
nork: Estcourt, L, et al.
Argitaratua: (2010) -
Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
nork: Stanworth, S, et al.
Argitaratua: (2010)